reports
- Mihail Dimitrov
- Veselin Radoychev Please Change Surname
Morning Bulletin - 2 June 2025
SOFIX (999.39, +0.58%) closed a few ticks away from the psychological level of 1000, something we haven’t witnessed since 2008. The excellent Q1 financial results raised Doverie United Holding (DUH, BGN 9.00, +3.45%) while Sirma Group Holding (SGH, BGN 1.46, +2.10%) jumped on the back of buy-back buying power. Ex-dividend date weighed on Advance Terrafund (ATER, BGN 2.92, -2.01%) while Smart Organic (SO, BGN 31.20, -2.50%) and First Investment Bank (FIB, BGN 5.10, -1.54%) suffered from small spe...
- Mihail Dimitrov
- Veselin Radoychev Please Change Surname
Weekly bulletin - 19 May - 23 May 2025
The Bulgarian stocks marked a positive week, while the global markets suffered pullbacks and volatility, as new threats were tapping the brakes on investor optimism. The local benchmark SOFIX added 2.6% to settle at 981.32 and the broader BGBX40 (183.32, +1.7%) and BGTR30 (922.11, +2.6%) moved similar. Three SOFIX members were the top gainers in our list of selected securities – the technology blue chips Sirma Group Holding (SGH, BGN 1.43, +19.2%) and Wiser Technologies (WISR, BGN 5.35, +7.4%) a...
Achieve Life Sciences to Present at the Jefferies Global Healthcare Co...
Achieve Life Sciences to Present at the Jefferies Global Healthcare Conference SEATTLE and VANCOUVER, British Columbia, May 28, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment of nicotine dependence for smoking cessation, today announced that the company will present at the Jefferies Global Healthcare Conference being held June 3–5, 2025, in New York City. Rick Stewart, Chief Executive Officer of Achieve, will present on Wednesday, Jun...
- Mihail Dimitrov
- Veselin Radoychev Please Change Surname
Morning Bulletin - 22 May 2025
The Bulgarian equity market had another strong showing on Wednesday and continued its upside trend, building on recent gains. The major indexes endured significant positive actions on broad base and advanced in range between 0.31% and 1.21%. The upside bias was supported by large cap names - First Investment Bank (FIB, BGN 5.24, +4.80%), Smart Organic (SO, BGN 33.80, +2.42%), Doverie (DUH, BGN 8.50, +2.66%) as Sirma Group (SGH, BGN 1.43, +13.49%) stepped in front of this list after a significant...
- Mihail Dimitrov
- Veselin Radoychev Please Change Surname
Morning Bulletin - 21 May 2025
The major indexes closed near session highs on Wednesday, reflecting the continuous buying interest in Bulgarian Stock Exchange (BSE, BGN 8.60, +3.61%), Sirma Group (SGH, BGN 1.26, +4.13%) and Smart Organic (SO, BGN 33.00, +3.13%). First Investment Bank (FIB, BGN 5.00) attracted more investors after the announcement of additional items to be voted on the GSM and led the gainers with 13.64% advance, revealing the investors optimism about some key phrases in the proposal. Doverie (DUH, BGN 8.28, -...
Achieve Life Sciences to Present New Data at the 2025 ATS Internationa...
Achieve Life Sciences to Present New Data at the 2025 ATS International Conference Demonstrating that Cytisinicline Reduced Cravings and Nicotine Intake Oral Presentation to Highlight Key Benefits of Cytisinicline’s Dual Mechanism of Action to Pulmonary Specialists SEATTLE and VANCOUVER, British Columbia, May 20, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV) a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment of nicotine dependence for smoking cessation, today announced that additiona...
- Mihail Dimitrov
- Veselin Radoychev Please Change Surname
Weekly bulletin - 12 May - 16 May 2025
The local stock market gained some steam last week and ended on a positive note, ranging from 0.8% to 3.2%. The benchmark SOFIX added 3.2% to settle at 956.86, strongly supported by the renewed buying interest in high-tech blue chip Shelly Group (SLYG, EUR 42.80, +17.3%). The share became the weekly top gainer within our list of selected companies, followed by the less interesting Industrial Capital Holding (HIKA, BGN 2.56, +4.9%) and Monbat (MONB, BGN 2.60, +4.0%). On the other side, Speedy (SP...
- Mihail Dimitrov
- Veselin Radoychev Please Change Surname
Morning Bulletin - 19 May 2025
Key names like First Investment Bank (FIB, BGN 4.37, -5.41%), Doverie (DUH, BGN 8.62, -2.27%) and Chimimport (CHIM, BGN 0.695, -2.11%) met some selling pressure on Friday and influenced the daily outcome of the major indexes. SOFIX (956.86) slipped the most, interrupting 9-session winning trend with 0.49% loss, while BGBX40 (180.32, -0.25%) and BGTR30 (898.68, -0.44%) partly balanced with the positive price actions of Eleven Capital (11C, BGN 14.80, +8.03%) and Bulgarian Stock Exchange (BSE, BGN...
Achieve Life Sciences Reports First Quarter 2025 Financial Results and...
Achieve Life Sciences Reports First Quarter 2025 Financial Results and Highlights Updates in Cytisinicline Program Reiterates Planned Submission of an NDA for Cytisinicline to FDA in June 2025 Company to Host Conference Call at 8:30 AM EDT Today, Tuesday, May 13, 2025 SEATTLE and VANCOUVER, British Columbia, May 13, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment of nicotine dependence for smoking cessation, today announced its financ...
Achieve Life Sciences to Announce First Quarter 2025 Financial Results...
Achieve Life Sciences to Announce First Quarter 2025 Financial Results and Host Conference Call and Webcast on May 13, 2025 SEATTLE and VANCOUVER, British Columbia, May 06, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV) a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment of nicotine dependence for smoking cessation, today announced that it will report its first quarter 2025 financial results and provide a corporate update on the cytisinicline development program on Tuesday May 13, 2025, ...
- Mihail Dimitrov
- Veselin Radoychev Please Change Surname
Morning Bulletin - 2 May 2025
The Bulgarian stocks ended the week with no clear direction, as the leading local benchmark SOFIX lost 0.14% to close at 885.75. Trades with Advance Terrafund (ATER, BGN 3.02, -0.66%) formed more than half of SOFIX turnover, which pushed it above the 3-month average numbers. The top daily gainers within the benchmark were Doverie United Holding (DUH, BGN 8.24, +2.74 %), Bulgarian Stock Exchange (BSE, BGN 7.85, +2.61%) and Chimimport (CHIM, BGN 0.705, +2.17%). The high-tech blue chip Shelly Group...
- Mihail Dimitrov
- Veselin Radoychev Please Change Surname
Morning Bulletin - 30 April 2025
The Bulgarian equity market continued to be sluggish and the main indexed finished with small changes on Wednesday. Shelly (SLYG, EUR 33.70, +1.81%) and First Investment Bank (FIB, BGN 3.98, +1.53%) supported the indexes with moderate buying interest, while Eleven Capital (11C, BGN 13.00, -5.80%) and Agria Group (AGH, BGN 21.60, -3.57%) took over some sell pressure and placed BGTR30 (868.18, -0.36%) on negative territory. The volumes remained low as the trading activity was poor, though block tr...
- Mihail Dimitrov
- Veselin Radoychev Please Change Surname
Weekly bulletin - 22 April - 24 April 2025
The Bulgarian stocks ended the week with no clear direction, while the world equity markets recorded a relief rally, easing some of the growing tension over the past months and moving away from extreme pessimism. The leading local benchmark SOFIX added 0.3% to settle at 888.88, as all other major indexes kept to wider range from -0.2% to 0.8%. The industrial M+S Hydraulic (MSH, BGN 9.6, +4.9%) and the SOFIX member Sirma Group Holding (SGH, BGN 1.09, +3.8%) were on the top of the gainers in our l...
- Mihail Dimitrov
- Veselin Radoychev Please Change Surname
Morning Bulletin - 23 April 2025
The Bulgarian equity market had a quiet start of the short week with less enthusiasm and poor trading activity. Neochim (NEOH, BGN 24.60, +5.13%), Sirma (SGH, BGN 1.08, +2.86%) and Smart Organic (SO, BGN 28.00, +1.45) were the leading names among gainers, though all major indexes settled on the negative side – SOFIX (880.53%, -0.60%) , BGBX40 (169.12, -0.49%) , BGTR30 (864.88, -0.11%) and BGREIT (214.10, -0.25%), as the negative price actions in First Investment Bank (FIB, BGN 3.80, -6.40%), Syn...
Achieve Life Sciences Announces Cytisinicline Phase 3 ORCA-3 Trial Pub...
Achieve Life Sciences Announces Cytisinicline Phase 3 ORCA-3 Trial Publication on Smoking Cessation in JAMA Internal Medicine ORCA-3 Demonstrated a Significant Increase in Quitting and Reduction in Nicotine Cravings for Cytisinicline-Treated Participants Compared to Placebo Cytisinicline New Drug Application (NDA) Submission to FDA Planned for June 2025 SEATTLE and VANCOUVER, British Columbia, April 21, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisiniclin...
- Mihail Dimitrov
- Veselin Radoychev Please Change Surname
Morning Bulletin - 31 March 2025
Positive sentiment on Friday raised SOFIX by 0.80% to 910.69, a level we haven’t seen since 2008. Eurohold (EUBG, BGN 1.94, +2.11%), First Investment Bank (FIB, BGN 4.08, +2.00%) and Shelly Group (SLYG, EUR 37.90, +1.61%) led the daily gainers with moderate daily volume. Negative impact on the main index came from Sirma Group Holding (SGH, BGN 1.10, -0.90%) and Wiser (WISR, BGN 4.90, -0.81%). BGBX40 (173.89, +0.56%) also registered green session on the back of Industrial Capital Holding (HIKA, B...
- Mihail Dimitrov
- Veselin Radoychev Please Change Surname
Morning Bulletin - 21 March 2025
Huge opposite moves of index members fixed SOFIX almost unchanged at 901.53 (-0.07%) on Thursday. Agria Group Holding (AGH, BGN 21.10, -4.09%), Bulgarian Stock Exchange (BSE, BGN 7.75, -0.64%) and Central Cooperative Bank (CCB, BGN 1.61, -0.62%) slipped without significant daily volume while Elana Agrocredit (EAC, BGN 1.06, -0.93%) suffered from big selling pressure and closed negative. Sirma Group Holding (SGH, BGN 1.10, +2.80%) and Chimimport (CHIM, BGN 0.745, +1.36%) and Bulgarian Real Estate...
Achieve Life Sciences Reports Financial Results for Fourth Quarter and...
Achieve Life Sciences Reports Financial Results for Fourth Quarter and Year-End 2024 and Provides Update on the Cytisinicline Development Program Reiterates Planned Cytisinicline NDA Submission Expected at the End of Q2 2025 Company to Host Conference Call at 8:30 AM EDT Today, Tuesday, March 11, 2025 SEATTLE and VANCOUVER, British Columbia, March 11, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment of nicotine dependen...
Achieve Life Sciences to Present at the Barclays 27th Annual Global He...
Achieve Life Sciences to Present at the Barclays 27th Annual Global Healthcare Conference SEATTLE and VANCOUVER, British Columbia, March 07, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment of nicotine dependence for smoking cessation, today announced that the company will be presenting at the Barclays 27th Annual Global Healthcare Conference to be held March 11-13, 2025, in Miami, FL. Rick Stewart, Chief Executive Officer of Achieve, w...
Achieve Life Sciences to Announce Fourth Quarter and Year-End 2024 Fin...
Achieve Life Sciences to Announce Fourth Quarter and Year-End 2024 Financial Results and Host Conference Call and Webcast on March 11, 2025 SEATTLE and VANCOUVER, British Columbia, March 06, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment of nicotine dependence for smoking cessation, today announced it will report its fourth quarter and year-end 2024 financial results and provide an update on the cytisinicline development program on Tue...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.